Goldman Sachs
STTK icon

Goldman Sachs’s Shattuck Labs STTK Stock Holding History

Goldman Sachs’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Buy
593,324
+401,882
+210% +$2.51M ﹤0.01% 4059
2026
Q1 		$1.23M Buy
191,442
+63,277
+49% +$300K ﹤0.01% 4942
2025
Q4 		$468K Buy
128,165
+111,365
+663% +$266K ﹤0.01% 5632
2025
Q3 		$40.2K Sell
16,800
-308,454
-95% -$377K ﹤0.01% 6194
2025
Q2 		$258K Buy
325,254
+222,941
+218% +$216K ﹤0.01% 5529
2025
Q1 		$97.2K Sell
102,313
-138,549
-58% -$171K ﹤0.01% 5791
2024
Q4 		$291K Buy
240,862
+132,201
+122% +$164K ﹤0.01% 5507
2024
Q3 		$379K Buy
108,661
+15,162
+16% +$56.5K ﹤0.01% 5200
2024
Q2 		$361K Sell
93,499
-164,640
-64% -$1.34M ﹤0.01% 5004
2024
Q1 		$2.31M Buy
258,139
+243,354
+1,646% +$2.23M ﹤0.01% 3770
2023
Q4 		$105K Buy
+14,785
New +$40.3K ﹤0.01% 5286
2023
Q2 		– Sell
-10,621
Closed -$31.2K – 6055
2023
Q1 		$31.2K Sell
10,621
-4,392
-29% -$15.5K ﹤0.01% 5620
2022
Q4 		$34.5K Sell
15,013
-6,619
-31% -$16.6K ﹤0.01% 5641
2022
Q3 		$58K Sell
21,632
-10,099
-32% -$37.9K ﹤0.01% 5784
2022
Q2 		$129K Sell
31,731
-68,624
-68% -$248K ﹤0.01% 5787
2022
Q1 		$428K Buy
100,355
+31,792
+46% +$180K ﹤0.01% 5426
2021
Q4 		$583K Buy
68,563
+52,031
+315% +$717K ﹤0.01% 5269
2021
Q3 		$337K Sell
16,532
-124,282
-88% -$2.66M ﹤0.01% 5426
2021
Q2 		$4.08M Sell
140,814
-22,092
-14% -$646K ﹤0.01% 3524
2021
Q1 		$4.76M Buy
+162,906
New +$6.84M ﹤0.01% 3179

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs's STTK Position: Q2 2026 in Review

Goldman Sachs increased its Shattuck Labs (STTK) stake by 210% in Q2 2026, buying an estimated $2.51M and bringing the position to 593,324 shares worth $4.12M. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Goldman Sachs first reported a position in STTK in Q1 2021 and has held it in 20 quarters since. The position peaked at $4.76M in Q1 2021. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Goldman Sachs held 593,324 shares of Shattuck Labs worth $4.12M as of Q2 2026.
  • Goldman Sachs bought 401,882 Shattuck Labs shares in Q2 2026, an estimated $2.51M.
  • Shattuck Labs made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4059 holding.
  • Goldman Sachs first reported a position in Shattuck Labs in Q1 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Shattuck Labs position peaked at $4.76M in Q1 2021.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.